4//SEC Filing
Poulton Stuart 4
Accession 0001209191-23-010509
CIK 0001503802other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:07 PM ET
Size
7.9 KB
Accession
0001209191-23-010509
Insider Transaction Report
Form 4
Poulton Stuart
EVP, Chief Development Officer
Transactions
- Sale
Common Stock
2023-02-15$3.19/sh−5,665$18,071→ 64,335 total - Sale
Common Stock
2023-02-15$3.23/sh−8$26→ 64,327 total - Sale
Common Stock
2023-02-15$3.16/sh−196$619→ 64,131 total
Footnotes (1)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001942597
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:07 PM ET
- Size
- 7.9 KB